Results 71 to 80 of about 20,556 (211)

Gene mutations related to clarithromycin resistance.

, 2016
Gene mutations related to clarithromycin resistance.
Yoshio Yamaoka (187580), Ari Fahrial Syam (829925), Jimmy Bradley Waleleng (3374159), Junko Akada (618874), Iswan Abbas Nusi (829927), Willy Brodus Uwan (3374162), Fardah Akil (829930), David Simanjuntak (829932), I Dewa Nyoman Wibawa (3374183), Lukman Hakim Zein (3374165), Muhammad Miftahussurur (615312), Dadang Makmun (829926), Syifa Mustika (3374174), Hasan Maulahela (3374186), Rumiko Suzuki (187579), Langgeng Agung Waskito (3374180), Yudith Annisa Ayu Rezkitha (829935), Fauzi Yusuf (3374171), Pangestu Adi (829933), Ummi Maimunah (3374189), Nasronudin (499228), Alexander Michael Joseph Saudale (3374177), Phawinee Subsomwong (829936), Dadik Rahardjo (3374168)   +23 more
core   +1 more source

Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus [PDF]

, 2014
OBJECTIVES: The ribosomal methylase Erm(41) confers inducible resistance to macrolides in Mycobacterium abscessus. The aim of this work was to systematically study and compare drug susceptibility to clarithromycin and azithromycin in M.
Böttger, Erik C, Maurer, Florian P, Castelberg, Claudio, Somoskövi, Akos, Quiblier, Chantal   +4 more
core   +1 more source

High Prevalence of hefA Efflux Pump Overexpression in Isolates of Helicobacter pylori Resistant to Clarithromycin

Antibiotics
Background/Objectives: Helicobacter pylori is a cause of chronic gastric infections and gastrointestinal carcinogenesis, with a prevalence of 20–90% around the world.
Marcela Villegas, Catalina Ortega, Krishna Gómez, Alvaro Cerda, Rolando Sepúlveda, Christian Lara, Luis Bustamante, Daniela Garcia, Luis Coppelli, Edmundo Hofmann, Armando Sierralta, Mónica Pavez   +11 more
doaj   +1 more source

Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral hospital in Switzerland

Swiss Medical Weekly, 2023
BACKGROUND AND AIMS: Due to increasing antibiotic resistance, various Helicobacter pylori eradication regimens other than clarithromycin-based therapies have been proposed.
Tobias Braendli, Valeria Schindler, Dominique Laurent Braun, Fritz R. Murray, Juliane Marie Hente, Daniel Pohl   +5 more
doaj   +1 more source

Detection of Clarithromycin-Resistant Helicobacter pylori in Stool Samples [PDF]

Journal of Clinical Microbiology, 2003
ABSTRACT The recognition of the role of Helicobacter pylori in gastric diseases has led to the widespread use of antibiotics in the eradication of this pathogen. The most advocated therapy, triple therapy, often includes clarithromycin.
FONTANA, CARLA, FAVARO, MARCO, PIETROIUSTI, ANTONIO, PISTOIA, ENRICO SALVATORE, GALANTE, ALBERTO, FAVALLI, CARTESIO   +5 more
openaire   +3 more sources

Exploring the Molecular Mechanisms of Macrolide Resistance in Laboratory Mutant Helicobacter pylori

Antibiotics
Resistance to clarithromycin, a macrolide antibiotic used in the first-line treatment of Helicobacter pylori infection, is the most important cause of treatment failure. Although most cases of clarithromycin resistance in H.
Meltem Ayaş, Sinem Oktem-Okullu, Orhan Özcan, Tanıl Kocagöz, Yeşim Gürol   +4 more
doaj   +1 more source

Risk Factors and Management of Gingival Enlargement: A Systematic Review and Meta‐Analysis

Journal of Clinical Periodontology, EarlyView.
ABSTRACT Objective To identify risk factors/indicators of gingival enlargement (GE) and to summarise evidence for its management. Methods A systematic review was undertaken following PRISMA guidelines and divided into PECOTS and PICOTS questions, related to risk factors/indicators and treatment studies, respectively.
Luigi Nibali, Emily Ming‐Chieh Lu, Helvis E. S. Paz, Jing Kang, Nagihan Bostanci, Georgios N. Belibasakis   +5 more
wiley   +1 more source

Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates

Infection and Drug Resistance, 2020
Qi Guo,1,2 Jianhui Chen,1,2 Shaoyan Zhang,1 Yuzhen Zou,1,2 Yongjie Zhang,1,2 Dongdong Huang,1 Zhemin Zhang,1 Bing Li,1 Haiqing Chu1,3 1Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433,
Guo Q, Chen J, Zhang S, Zou Y, Zhang Y, Huang D, Zhang Z, Li B, Chu H   +8 more
doaj  

Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand.

PLoS ONE, 2018
Mycobacterium abscessus is an important infectious agent highly associated with drug resistance and treatment failure. We investigated the drug resistance situation of M. abscessus in Northeast Thailand and the possible genetic basis for this.
Pimjai Ananta, Irin Kham-Ngam, Ploenchan Chetchotisakd, Prajuab Chaimanee, Wipa Reechaipichitkul, Wises Namwat, Viraphong Lulitanond, Kiatichai Faksri   +7 more
doaj   +1 more source

Rapid prediction of inducible clarithromycin resistance in Mycobacterium abscessus

Molecular and Cellular Probes, 2015
We have developed a single tube TaqMan(®) real-time PCR assay that differentiates the full-length and truncated erm(41) gene to predict inducible resistance to clarithromycin in Mycobacterium abscessus. A study of 87 clinical isolates found this assay to be 90.8% concordant to conventional drug susceptibility testing results for the prediction of ...
Yan Chun, Zhu, Kara K, Mitchell, Elizabeth J, Nazarian, Vincent E, Escuyer, Kimberlee A, Musser   +4 more
openaire   +2 more sources